Loading...
Loading...
Interrupting dual antiplatelet
therapy after 30 days following the implantation of a Resolute drug-eluting
stent from Medtronic, Inc.
MDT caused no increase in rates of stent
thrombosis at one year, according to a new analysis of the global RESOLUTE
clinical program presented today at the 24th Annual Transcatheter
Cardiovascular Therapeutics (TCT) scientific symposium.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in